In addition, it is important to note that a recent report by Fondevila et al. (102) showed that the expression of the LPI receptor GPR55 is increased in human and mouse models of NAFLD/NASH, and that LPI lipids can promote hepatic steatosis in a GPR55-dependent manner. The gene discussed is GPR55; the disease is metabolic dysfunction-associated steatotic liver disease.